FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791073178> ?p ?o ?g. }

• W2791073178 endingPage "252" @default.
• W2791073178 startingPage "252" @default.
• W2791073178 abstract "Ischemic brain injury triggers neuronal cell death by apoptosis via caspase activation and by necroptosis through activation of the receptor-interacting protein kinases (RIPK) associated with the tumor necrosis factor-alpha (TNF-α)/death receptor. Recent evidence shows RIPK inhibitors are neuroprotective and alleviate ischemic brain injury in a number of animal models, however, most have not yet undergone clinical trials and safety in humans remains in question. Dabrafenib, originally identified as a B-raf inhibitor that is currently used to treat melanoma, was later revealed to be a potent RIPK3 inhibitor at micromolar concentrations. Here, we investigated whether Dabrafenib would show a similar neuroprotective effect in mice subjected to ischemic brain injury by photothrombosis. Dabrafenib administered intraperitoneally at 10 mg/kg one hour after photothrombosis-induced focal ischemic injury significantly reduced infarct lesion size in C57BL6 mice the following day, accompanied by a markedly attenuated upregulation of TNF-α. However, subsequent lower doses (5 mg/kg/day) failed to sustain this neuroprotective effect after 4 days. Dabrafenib blocked lipopolysaccharides-induced activation of TNF-α in bone marrow-derived macrophages, suggesting that Dabrafenib may attenuate TNF-α-induced necroptotic pathway after ischemic brain injury. Since Dabrafenib is already in clinical use for the treatment of melanoma, it might be repurposed for stroke therapy." @default.
• W2791073178 created "2018-03-29" @default.
• W2791073178 creator A5001575849 @default.
• W2791073178 creator A5022756029 @default.
• W2791073178 creator A5025846764 @default.
• W2791073178 creator A5074923441 @default.
• W2791073178 date "2018-01-01" @default.
• W2791073178 modified "2023-10-18" @default.
• W2791073178 title "Dabrafenib, an inhibitor of RIP3 kinase-dependent necroptosis, reduces ischemic brain injury" @default.
• W2791073178 cites W1520369407 @default.
• W2791073178 cites W1523845694 @default.
• W2791073178 cites W1658228410 @default.
• W2791073178 cites W1862763039 @default.
• W2791073178 cites W1992575481 @default.
• W2791073178 cites W1995464318 @default.
• W2791073178 cites W2004378226 @default.
• W2791073178 cites W2012985988 @default.
• W2791073178 cites W2029159099 @default.
• W2791073178 cites W2029984783 @default.
• W2791073178 cites W2039254613 @default.
• W2791073178 cites W2043310375 @default.
• W2791073178 cites W2051297853 @default.
• W2791073178 cites W2056641170 @default.
• W2791073178 cites W2064877896 @default.
• W2791073178 cites W2065322133 @default.
• W2791073178 cites W2091900831 @default.
• W2791073178 cites W2092585655 @default.
• W2791073178 cites W2110796758 @default.
• W2791073178 cites W2121154174 @default.
• W2791073178 cites W2122547951 @default.
• W2791073178 cites W2131357993 @default.
• W2791073178 cites W2153891187 @default.
• W2791073178 cites W2158662692 @default.
• W2791073178 cites W2160875934 @default.
• W2791073178 cites W2162044478 @default.
• W2791073178 cites W2166262263 @default.
• W2791073178 cites W2167525800 @default.
• W2791073178 cites W2171729220 @default.
• W2791073178 cites W2172953381 @default.
• W2791073178 cites W2252918989 @default.
• W2791073178 cites W2357133200 @default.
• W2791073178 cites W2565402466 @default.
• W2791073178 cites W2739038514 @default.
• W2791073178 cites W2747047699 @default.
• W2791073178 doi "https://doi.org/10.4103/1673-5374.226394" @default.
• W2791073178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5879896" @default.
• W2791073178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29557374" @default.
• W2791073178 hasPublicationYear "2018" @default.
• W2791073178 type Work @default.
• W2791073178 sameAs 2791073178 @default.
• W2791073178 citedByCount "53" @default.
• W2791073178 countsByYear W27910731782018 @default.
• W2791073178 countsByYear W27910731782019 @default.
• W2791073178 countsByYear W27910731782020 @default.
• W2791073178 countsByYear W27910731782021 @default.
• W2791073178 countsByYear W27910731782022 @default.
• W2791073178 countsByYear W27910731782023 @default.
• W2791073178 crossrefType "journal-article" @default.
• W2791073178 hasAuthorship W2791073178A5001575849 @default.
• W2791073178 hasAuthorship W2791073178A5022756029 @default.
• W2791073178 hasAuthorship W2791073178A5025846764 @default.
• W2791073178 hasAuthorship W2791073178A5074923441 @default.
• W2791073178 hasBestOaLocation W27910731781 @default.
• W2791073178 hasConcept C185592680 @default.
• W2791073178 hasConcept C190283241 @default.
• W2791073178 hasConcept C25498285 @default.
• W2791073178 hasConcept C2776131300 @default.
• W2791073178 hasConcept C2777658100 @default.
• W2791073178 hasConcept C2778830669 @default.
• W2791073178 hasConcept C2994587330 @default.
• W2791073178 hasConcept C31573885 @default.
• W2791073178 hasConcept C502942594 @default.
• W2791073178 hasConcept C55493867 @default.
• W2791073178 hasConcept C71924100 @default.
• W2791073178 hasConcept C94030615 @default.
• W2791073178 hasConcept C98274493 @default.
• W2791073178 hasConceptScore W2791073178C185592680 @default.
• W2791073178 hasConceptScore W2791073178C190283241 @default.
• W2791073178 hasConceptScore W2791073178C25498285 @default.
• W2791073178 hasConceptScore W2791073178C2776131300 @default.
• W2791073178 hasConceptScore W2791073178C2777658100 @default.
• W2791073178 hasConceptScore W2791073178C2778830669 @default.
• W2791073178 hasConceptScore W2791073178C2994587330 @default.
• W2791073178 hasConceptScore W2791073178C31573885 @default.
• W2791073178 hasConceptScore W2791073178C502942594 @default.
• W2791073178 hasConceptScore W2791073178C55493867 @default.
• W2791073178 hasConceptScore W2791073178C71924100 @default.
• W2791073178 hasConceptScore W2791073178C94030615 @default.
• W2791073178 hasConceptScore W2791073178C98274493 @default.
• W2791073178 hasIssue "2" @default.
• W2791073178 hasLocation W27910731781 @default.
• W2791073178 hasLocation W27910731782 @default.
• W2791073178 hasLocation W27910731783 @default.
• W2791073178 hasLocation W27910731784 @default.
• W2791073178 hasOpenAccess W2791073178 @default.
• W2791073178 hasPrimaryLocation W27910731781 @default.
• W2791073178 hasRelatedWork W2511732103 @default.
• W2791073178 hasRelatedWork W2790945713 @default.

• next